Exane Derivatives’s Boeing BA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-200
Closed -$1.8K 705
2019
Q4
$1.8K Hold
200
﹤0.01% 503
2019
Q3
$22.2K Hold
200
﹤0.01% 395
2019
Q2
$58.1K Buy
+200
New +$72.9K 0.01% 379
2019
Q1
Sell
-90
Closed -$260K 667
2018
Q4
$260K Hold
90
0.05% 221
2018
Q3
$88.9K Sell
90
-100
-53% -$35.1K 0.02% 335
2018
Q2
$340K Buy
190
+90
+90% +$31K 0.06% 203
2018
Q1
$126K Sell
100
-400
-80% -$135K 0.03% 275
2017
Q4
$900 Buy
500
+250
+100% +$67.7K ﹤0.01% 492
2017
Q3
$17.4K Buy
+250
New +$58.3K ﹤0.01% 363

Other funds holding BA

Exane Derivatives's BA Position: Q2 2022 in Review

Exane Derivatives sold out of Boeing (BA) in Q2 2022, closing a stake of 657 shares — an estimated $126K sold.

Exane Derivatives first reported a position in BA in Q4 2014 and held it in 20 quarters. The position peaked at $6.44M in Q4 2018. 1,901 funds tracked by Wall St. Rank hold BA as of Q2 2022.

  • Exane Derivatives reported no remaining Boeing position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 657 Boeing shares in Q2 2022, an estimated $126K.
  • Exane Derivatives first reported a position in Boeing in Q4 2014 and held it in 20 quarters.
  • Exane Derivatives's Boeing position peaked at $6.44M in Q4 2018.
  • 1,901 funds tracked by Wall St. Rank held Boeing as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.